Eli Lilly Acquires Adverum Biotechnologies to Advance Gene Therapy for Vision Restoration
Eli Lilly and Company has announced a definitive agreement to acquire Adverum Biotechnologies, Inc., a clinical-stage biotechnology firm specializing in…
Eli Lilly and Company has announced a definitive agreement to acquire Adverum Biotechnologies, Inc., a clinical-stage biotechnology firm specializing in…
Global health authorities moved swiftly on Tuesday (September 23) to counter U.S. President Donald Trump’s remarks linking common medicines and…